It was shown that ALS lymphoblasts recapitulate features of affected MNs, such as alterations in TDP-43 homeostasis [5] and proven to be a suitable cell model platform to preclinical evaluation of novel TDP-43 phosphorylation inhibitors [10,11]. Here, TARDBP is linked to amyotrophic lateral sclerosis.